SEA: NZX and Media Release 30 September 2015. NZX link here. SeaDragon raises $10.009 million via rights offer and shortfall bookbuild, and additional placement Successful capital raising at $0.008 per share facilitates the completion of the company’s new Omega-3 fish oil refinery. New Zealand’s leading refiner and blender of high-quality fish oils SeaDragon Limited (NZX:SEA) today […]
Link here. 30 September 2015. Highlights: BARDA contract commits initial USD16.9m to support Avita’s FDA approval trial for treatment of thermal burn injuries and procure 5000-plus ReCell® devices. Contract also establishes a strategic, Avita-managed stockpile for ReCell® devices to supply nationally. A further potential to receive USD37M in contract options to support additional clinical trials and […]
30 September 2015. Link here. ..Three independent studies support the positive impact of Smartinhaler™ Platform in paediatric asthma. ..144% increase in adherence and 37% reduction in oral steroids indicating reduced severe exacerbations. ..Data disclosed at prestigious European Respiratory Congress in Amsterdam. ..Adds to data on Adherium’s SmartInhaler published in Lancet Respiratory Medicine Adherium Limited (ASX: ADR), […]
DUBLIN, Ireland, Sept. 29, 2015 (GLOBE NEWSWIRE). Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced receipt of US$3.2 million in cash under the Australian Federal Government’s Research and Development (R&D) Tax Incentive program. This program provides a 45 percent refundable tax offset for qualifying R&D in Australia, where Nexvet conducts its drug discovery […]
18 September, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, notes two recent legal settlements — awarding funding for the purchase of a REX robot and funding for Robot-Assisted Physiotherapy with REX. These developments help to establish an important principle – that individuals […]
DUBLIN, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it has secured a dedicated biologics manufacturing facility in Tullamore, Ireland. The transaction is supported the Irish Government’s Department of Jobs, Enterprise & Innovation through IDA Ireland, their foreign investment agency. BioNua Limited, a wholly-owned subsidiary […]
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: